Literature DB >> 2362

Long-term perhexiline maleate and liver function.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2362      PMCID: PMC1638604          DOI: 10.1136/bmj.1.6002.133

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Perhexilene maleate in treatment of angina pectoris.

Authors:  L J Lyon; M A Nevins; S Risch; S Henry
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

2.  Clinical evaluation of perhexiline maleate in patients with angina pectoris.

Authors:  C J Burns-Cox; K P Chandrasekhar; H Ikram; T H Peirce; J Pilcher; C D Quinlan; J R Rees
Journal:  Br Med J       Date:  1971-12-04
  2 in total
  5 in total

Review 1.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

2.  Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy.

Authors:  E Singlas; M A Goujet; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

3.  Perhexiline maleate toxicity on human liver cell lines.

Authors:  J Y Le Gall; A Guillouzo; D Glaise; Y Deugnier; M Messner; M Bourel
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

4.  Liver damage associated with perhexiline maleate.

Authors:  D Lewis; H C Wainwright; M C Kew; S Zwi; C Isaacson
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

5.  Impaired oxidation of debrisoquine in patients with perhexiline liver injury.

Authors:  M Y Morgan; R Reshef; R R Shah; N S Oates; R L Smith; S Sherlock
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.